here is the official release from Moderna

來源: fuz 於 2020-12-01 07:24:47 [] [博客] [舊帖] [給我悄悄話] 本文已被閱讀： 次 (1057 bytes)
本文內容已被 [ fuz ] 在 2020-12-01 07:27:57 編輯過。如有問題，請報告版主或論壇管理刪除.

https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study

Today’s primary analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine efficacy of 94.1%. A secondary endpoint analyzed severe cases of COVID-19 and included 30 severe cases (as defined in the study protocol) in this analysis. All 30 cases occurred in the placebo group and none in the mRNA-1273 vaccinated group. There was one COVID-19-related death in the study to date, which occurred in the placebo group.

 

 

 

所有跟帖： 

• 有了原文，意思就更清楚 -楊別青- ♂ 給 楊別青 發送悄悄話 楊別青 的博客首頁 (0 bytes) () 12/01/2020 postreply 10:33:30

請您先登陸，再發跟帖！

發現Adblock插件

如要繼續瀏覽
請支持本站 請務必在本站關閉/移除任何Adblock

關閉Adblock後 請點擊

請參考如何關閉Adblock/Adblock plus

安裝Adblock plus用戶請點擊瀏覽器圖標
選擇“Disable on www.wenxuecity.com”

安裝Adblock用戶請點擊圖標
選擇“don't run on pages on this domain”